| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |